Last quarter (Q3 2023), HCW Biologics's total revenue was $853.10K, a decrease of -52.84% from the same quarter last year. In Q3, HCW Biologics's net income was $-4.94M. See HCW Biologics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 2.82M	$ 6.70M	-	$ 4.10M	$ 0.00
Cost of Revenue	$ -365.54K	$ 4.14M	-	-	-
Gross Profit	$ 1.04M	$ 2.56M	-	-	-
Operating Expense	$ 9.14M	$ 17.67M	$ -13.37M	$ 9.92M	$ 7.37M
Operating Income	$ -21.31M	$ -15.08M	$ -13.37M	$ -5.82M	$ -7.37M
Net Non Operating Interest Income Expense	$ -1.09M	$ -126.66K	$ 505.37K	$ 22.32K	$ 72.35K
Other Income Expense	$ -1.76M	$ -304.74K	$ -505.37K	-	-
Pretax Income	$ -19.73M	$ -14.92M	$ -12.86M	$ -5.80M	$ -7.29M
Tax Provision	$ -8.54K	$ -655.14K	$ -2.09K	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-
Net Income Common Stockholders	$ -19.73M	$ -14.92M	$ -12.86M	$ -5.80M	$ -7.29M
Basic EPS	$ -0.61	$ -0.42	$ -0.69	$ -0.24	$ -0.30
Diluted EPS	$ -0.55	$ -0.42	$ -0.69	$ -0.24	$ -0.30
Basic Average Shares	$ 143.54M	$ 35.82M	$ 18.77M	$ 24.43M	$ 24.43M
Diluted Average Shares	$ 143.54M	$ 35.82M	$ 18.77M	$ 24.43M	$ 24.43M
Dividend Per Share	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-
Rent Expense Supplemental	-	-	-	$ 100.97K	$ 77.11K
Total Expenses	$ 8.77M	$ 21.80M	$ -13.37M	$ 9.92M	$ 7.37M
Net Income From Continuing And Discontinued Operation	$ -19.73M	$ -14.90M	$ -12.86M	$ -5.80M	$ -7.29M
Normalized Income	$ -6.80M	$ -15.58M	-	$ -5.80M	$ -7.29M
Interest Expense	-	-	-	-	-
EBIT	$ -18.71M	$ -14.80M	$ -12.86M	$ -5.82M	$ -7.37M
EBITDA	$ -17.59M	$ -14.08M	$ -12.32M	$ -5.25M	$ -6.94M

Currency in USD

HCW Biologics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing